IMCIVREE 10 mg/ml, Injektionslösung

7680696940014 CH-69694 Injektionslösung
IMCIVREE 10 mg/ml, Injektionslösung
IMCIVREE 10 mg/ml, Injektionslösung
IMCIVREE 10 mg/ml, Injektionslösung
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
09/06/2026
Summary of Product Characteristics
Français
09/06/2026
Summary of Product Characteristics
Italien
09/06/2026
Patient information leaflet
Allemand
23/05/2026
Patient information leaflet
Français
23/05/2026
Patient information leaflet
Italien
23/05/2026

Detailed composition

Substance Quantity Type Category
setmelanotidum
10.0 MG Substance Wirkstoff (Principe actif)
N-(carbonyl-methoxypolyethylenglycoli 2000)-1,2-distearoyl-sn-glycero-3-phosphoethanolaminum natricum
- Substance HNIDK
alcohol benzylicus
10.0 MG Substance HBESI
carmellosum natricum
- Substance HNIDK
mannitolum
- Substance HNIDK
phenolum
- Substance Konservierungsstoff (Conservateur)
dinatrii edetas
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
acidum hydrochloridum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
1.64 MG Substance HBESI

Authorization holder

Rhythm Pharmaceuticals Switzerland GmbH

6300 Zug

Authorization information

Swissmedic authorization number
69694
Drug name
IMCIVREE, Injektionslösung
Galenic form
LSINJ
ATC Code
A08AA12
Authorization status
Z
Dispensing category
B
First authorization
23/06/2025
Authorization expiration date
22/06/2030
IT Number
01.11.0.
Domain
Human medicine
Field of application
bei Erwachsenen und Kindern ab 2 Jahren zur Behandlung von Adipositas und zur Kontrolle des Hungergefühls im Zusammenhang mit genetisch bestätigtem Bardet-Biedl-Syndrom (BBS), durch Funktionsverlustmutationen bedingtem biallelischem Proopiomelanocortin (POMC)-Mangel (einschliesslich PCSK1) oder biallelischem Leptinrezeptor (LEPR)-Mangel

Package details

Description (FR)
IMCIVREE 10 mg/ml sol inj 10 mg 1 pce
Description (DE)
IMCIVREE 10 mg/ml Inj Lös 10 mg 1 Stk
Market launch
03/12/2025
Narcotic (BTM)
No
Buy us a coffee Explore the data